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ABSTRACT
Blood transfusion is still an irreplaceable therapeutic modality, widely applied to medical 
care. Clinical interviews and laboratory testing for transfusion-transmitted infections (TTI) 
are routinely performed to prevent TTI among the recipients. However, there is still a residual 
risk of TTI, and some blood banks have adopted the confidential unit exclusion (CUE) as 
an additional safety strategy. In this study, we investigated the demographic characteristics 
and laboratory results of the screening of TTI among blood donors who opted for the 
CUE, compared to blood donors who did not opt for the CUE. In this study, we included 
32,261 blood donations collected in a single blood bank in Sao Paulo, Brazil. A very small 
proportion of donors (0.25%) opted for the CUE. They were mainly single males and were 
more likely to have HBV, syphilis, and other positive results in the combined screening for 
TTI, in comparison with those who did not opt for the CUE. This difference was statistically 
significant in both the univariable and the multivariable analysis adjusted for age, gender , 
marital status and years of schooling. Our findings highlight that CUE may be a useful tool 
to improve the safety for blood recipients, but its efficiency is context-dependent. 
KEYWORDS: Blood donors. Transfusion. Screening. Confidential unit exclusion. 
Transfusion-transmitted infections. 
INTRODUCTION
Blood transfusion is still an irreplaceable therapeutic modality, widely applied 
to medical care. In the United States (USA) alone, 13.6 million units of whole 
blood and red blood cells are collected and nearly 21 million blood components are 
transfused yearly1. In Europe, 18,374,971 units of red blood cells were donated, and 
20,674,603 transfusions occurred in 20172. In Brazil, a yearly average of 3,608,436 
blood donations was registered between 2014 and 2016, and in 2016 alone 2,840,988 
transfusions were performed in the country3. 
Preventing transfusion-transmitted infections (TTI) among recipients is a central 
issue in the blood transfusion setting. The screening of blood donors includes a 
standardized interview addressing clinical and behavioral aspects; laboratory testing 
for hepatitis B, hepatitis C, HIV, syphilis, HTLV-1/2; and addicional screening tests 
for TTI such as Chagas disease and malaria in endemic areas4-6. The laboratory 
techniques used in blood donor screening include serological and molecular tests7. 
Despite the meticulous screening process, there is still a residual risk of TTI. 
During the interview, blood donor candidates may omit information on exposures 
or symptoms related to TTI because they believe that their blood is safe, or because 
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they feel some of the questions are too intimidating8. In 
addition, some donors may have limited understanding 
of the questions asked during the interview, particularly 
those concerning sexuality and sexual behaviors. For 
example, some donors may neglect the concept of sexually 
transmitted infection (STI) and may deny any previous 
episode even though they have already had an STI; some 
donors may also not consider oral and anal sex within 
the concept of sex, even when the definitions are stated 
by the interviewer9. Some donors may deliberately omit 
risk exposures because they want their blood to be tested 
for HIV and other STI without having to undergo the 
testing procedure in a conventional healthcare facility. 
Finally, some donors may inaccurately answer to interview 
questions because blood donation is actually an excuse 
to miss work10. As for the laboratory screening of blood 
samples, the main limitation is the risk of false-negative 
results, which may still occur mainly during the initial stage 
of an infection, also known as the eclipse phase. Although 
this period has been significantly reduced with the use of 
molecular tests, it is still associated with a residual risk of 
TTI11,12. In Brazil, some studies suggest that the residual 
risk of TTI is higher than the one seen in the US or Europe, 
highlighting the need for additional measures to further 
decrease this risk13. 
Aiming at further reducing the risk of TTI, some blood 
banks have adopted the confidential unit exclusion (CUE)14. 
The blood donor is asked to confidentially answer if 
his/her blood is safe for donation in a separate query after 
the clinical interview. If the donor opts for the CUE, the 
unit is sent for laboratory testing of TTI, but it is not sent 
for donation6.
The CUE is used in many blood banks based on the 
fact that the interview and laboratory screening are not 
perfectly sensitive in capturing all TTI4. Furthermore, 
some specialists argue that this strategy helps preventing 
the spread of other emerging infectious agents that may 
be transmitted through a blood unit but are not routinely 
tested15. However, the CUE may also result in unnecessary 
waste of a high number of blood units in a scenario of 
scarce supplies, and the effectiveness of the CUE in 
correctly identifying units with TTI has been challenged 
in several studies15-21. The effectiveness of the CUE is 
also context-dependent. For example, among donors with 
low level of education, errors in the selection of the CUE 
option may be more frequent than in other groups, due to 
the misunderstanding of the instrument22. In this study, 
we investigated demographic characteristics and results of 
laboratory screening for TTI among blood donors who opted 
for the CUE, compared to blood donors who did not opt for 
the CUE in a blood bank in Sao Paulo, Brazil.
MATERIALS AND METHODS
In this cross-sectional study, we included consecutive 
blood donations that took place in the blood bank of 
Hospital Israelita Albert Einstein between February 
2015 and December 2019. We included donations from 
sporadic donors, defined as those with up to one donation 
per year. For donors with more than one donation per year 
in the complete study period, regardless of the response 
for the CUE or the TTI screening tests results, only the 
first donation was considered for the study. Donations 
from replacement donors were excluded, assuming that 
replacement donations have different characteristics, such 
as a lower percentage of donors who are motivated by the 
access to screening test results, or a higher percentage 
of donors who will omit information on risk exposures 
driven by the desire to replenish blood supplies, although 
this evidence is still controversial23. We also excluded 
donations of platelets, leukocytes and bone marrow stem 
cells. Non-identifiable data including demographics, the 
CUE option, and laboratory TTI screening tests results 
were extracted from the institutional database. No 
additional tests were performed in stored samples and 
no additional information was collected from the donors 
included in the study. 
The question on the CUE is performed immediately 
after the clinical interview and before the blood donation. 
The attendant (physician or nurse) explains that the CUE is 
confidential and asks if the donor feels comfortable that his/
her blood can be transfused into a recipient. The attendant 
shows a computer screen with two options: a green box 
saying “yes”, and a red box saying “no”. While the donor 
is selecting his/her answer, the blood bank attendant turns 
his face in the opposite direction of the screen. 
The characteristics of study participants are presented 
using descriptive statistics. Comparisons between 
participants according to the CUE option were performed 
using chi square tests for categorical variables and T tests 
for numerical variables. We analyzed the association 
between the CUE option and TTI screening results using a 
chi square test and a multivariable logistic regression model 
to investigate if the CUE was associated with a positive 
result in the TTI screening, independently of covariates. 
For all analyses, we used the software Stata, version 
15.1 (StataCorp., College Station, TX, USA). Two‐tailed 
p<0.05 were considered statistically significant for all the 
comparisons.
Serological tests for the screening of blood donors 
(anti-HIV, HBsAg, Anti-HBc, anti-HTLV-1/2, anti-
syphilis and anti-chagas disease) were performed using the 
ARCHITECT i2000SR immunoassay analyzer (ABBOTT 
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Diagnostics, Chicago, USA). The real-time Polymerase 
Chain Reaction (PCR) tests to detect viral nucleic acids 
of HIV/ HCV/ HBV were performed using the COBAS® 
S201System, Roche NAT instruments (Roche, Basel, 
Switzerland). All tests were conducted according to the 
manufacturer’s instructions. 
This study was approved by the institutional Ethics 
Committee with exemption of the informed consent 
application (approval Nº 4.004.397).
RESULTS
Between February 2015 and December 2019, 32,261 
blood donations were eligible for enrollment in the study. Of 
those, 32,179 did not opt for the CUE and 82 did (0.25%). 
Demographics and TTI screening results are described in 
Table 1. Donors opting for the CUE were more likely males 
(p<0.001) and single (p=0.039); results from the laboratory 
tests revealed that this group had a higher prevalence of 
positive tests for HBV (p=0.016) and syphilis (p=0.001). 
Among donors who did not opt for the CUE, 694 (2.2%, 
95% CI 2.0-2.3) had a positive result among the TTI 
screening tests; among those who opted for the CUE, 5 
(6.1%, 95% CI 2.0-13.7) had a positive result among the 
TTI screening tests (p=0.033). 
Table 2 presents results of the multivariable logistic 
regression addressing factors associated with a positive 
result in any of the TTI screening tests. The model included 
Table 1 - Demographic characteristics of the study participants and results from the screening tests for transfusion-transmitted 
infections, according to the confidential unit exclusion (CUE) option.
Donnors who did 
not opt for the CUE 
N=32,179
Donnors who 
opt for the CUE 
N=82
p-value
Male gender (%) 16,974 (52.8) 61 (74.4) <0.001
Mean age (standard deviation) 35.4 (11.7) 33.3 (10.8) 0.097
Ethnicity (%)  
    White/caucasian  
    Black  
    Mixed  
    Asian  
    Native  




















    Elementary or incomplete middle school  
    Middle school  
    High school  
    Undergraduation (College)  
    Graduation   



















Marital status (%) 
    Single  
    Married/common-law marriage  
    Divorced/widowed  















    Serology  











    HBs Ag serology  











    Serology  










HTLV (%) 58 (0.2) 0 (0) 1.000 
Syphilis (%) 270 (0.8) 5 (6.1) 0.001 
Chagas disease (%) 52 (0.2) 1 (1.2) 0.126 
Any positive transfusion-transmitted infection 
in the screening test (%) 694 (2.2) 5 (6.1) 0.033
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age, gender, marital status, education and the CUE option. 
The model showed statistically significant associations with 
older age (OR= 1.03; 95% CI 1.02-1.03; p < 0.001), lower 
education level (linear trend p < 0.001), and with the CUE 
option (OR = 3.19, CI 95% 1.28-7.95; p = 0.013). 
DISCUSSION
In this study including 32,261 blood donations collected 
in a single blood bank in Sao Paulo, Brazil, we showed 
that a very small proportion (0.25%) of donors opted for 
the CUE. These donors were more often single males 
and were more likely than donors who did not opt for the 
CUE to have HBV, syphilis, and any positive results in 
the combined laboratory screening of TTI. This difference 
was statistically significant in both, the univariable and 
the multivariable analysis adjusted for age, gender, marital 
status and schooling (education level). 
Our findings highlight that the CUE may be a useful 
tool to improve the safety for blood recipients, without 
unnecessary wasting of an exceeding number of blood units. 
In addition, our results suggest that some groups of donors, 
including single males, may benefit from educational 
strategies that highlight the importance of preventing TTI 
among blood recipients. Furthermore, these groups could 
benefit from interventions to distinguish donated blood 
unit testing from diagnostic testing in a patient with risk 
factors for a TTI. 
The Ministry of Health of Brazil has implemented the 
CUE in 200415, resulting in a high incidence of the CUE in 
the country; currently, 1.1% of all donations are discarded 
due to the CUE and 2.5% of all donations are discarded due 
to a prior CUE from the same donor. In contrast, 0.22% 
of the blood donations registered in the USA had used the 
CUE strategy until 1992, when the CUE was withdrawn 
due to a low efficiency in reducing TTI14. Similarly, a 
study conducted in Canada suggested that the CUE has a 
limited capacity to predict infections in the eclipse period 
(i.e., those that would not be revealed by the laboratory 
screening tests) and has rarely detected blood units from 
donors with exposures that had not been identified in the 
routine interview18. On the other hand, a study conducted 
in Iran showed that the CUE was associated with a higher 
prevalence of HBV, HCV and HIV19. Interestingly, a 
study from Germany showed that the proportion of donors 
opting for the CUE was higher when nurses conducted the 
interview when compared to medical doctors, and when the 
CUE form was submitted anonymously instead of being 
delivered to a provider. This study has also shown that the 
format and colors used in the CUE form may influence 
the donor’s understanding of the process15. These factors 
highlight that the CUE varies according to different cultural 
and epidemiological contexts. Our study included blood 
donors from a single institution, typically attended by 
patients with higher educational and socioeconomic status. 
This may in part explain why the proportion of donors 
opting for the CUE in our study is closer to data from the 
USA than to the national reference. While the sensitivity 
of the CUE was relatively low, detecting only 5 out of 699 
donors with at least one positive result for TTI, the CUE was 
still significantly associated with TTI in both the univariable 
and the multivariable analysis. 
Our study has a few limitations. We were restricted to a 
single blood bank, which represented a limited blood donor 
population, so our results should be interpreted with caution 
in different contexts. Our study used serological screening 
tests and did not include additional confirmation exams. 
In addition, we analyzed the association between CUE 
Table 2 - Multivariable logistic regression addressing factors associated with a positive result in any screening test for transfusion-
transmitted infections.  
Odds Ratio 95% CI p-value
Age (per year increase) 1.03 1.01 - 1.03 0.000
Male gender 0.96 0.82 - 1.27 0.668
Marital status 
     Single 
     Married/common-law marriage 














     Elementary or incomplete middle school  
     Middle school  
     High school  
     Undergraduation (College)  









0.51 - 1.39 
0.47 - 1.09 








Option for the confidential unit exclusion (CUE) 3.19 1.28 - 7.95 0.013
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and TTI screening tests, but we were unable to address 
if donors opting for the CUE were more likely to be in 
the window period for TTI; similarly, because we opted 
for using a cross-sectional design, we were also unable to 
obtain follow-up samples from donors who opted for the 
CUE to investigate if the CUE is associated with subsequent 
seroconversion to TTI. 
Although the CUE remains a controversial procedure 
in the blood donation setting, it is also debatable if the 
central question in the currently used version of the CUE 
(“is your blood safe for donation?”) should be replaced by 
a less subjective, non-judgmental question. For instance, a 
question focused on the eclipse phase for HIV laboratory 
detection (“have you had unprotected sex in the past 
two weeks?”) or a question tackling a potential need for 
diagnostic tests as the main reason for donation (“do you 
want your sample to be tested but not donated?”) might be 
suitable to improve the CUE procedure and further increase 
the safety for recipients.
Since the publication of the update of technical 
standards for the hemotherapy activity by the Ministry of 
Health of Brazil in 2016, the CUE became a non-mandatory 
recommendation24. After the implementation of this 
guideline, some points are still controversial: what to do 
with the donor who excludes himself in some donations 
and not in others; what to do with the components coming 
from non-self-excluded seronegative donations by those 
aforementioned donors; what is the amount and impact of 
the donor’s lack of understanding about the CUE process 
in our country; what is the risk of stigmatizing the self-
excluded donor due to the lack of understanding about the 
CUE process, among others. Replacement donors may 
understand the blood donation process better than sporadic 
donors, since they regularly donate blood, are familiar with 
the blood bank workflow and may be acquainted with the 
importance of blood safety. Brazil is a continental country, 
with significant regional heterogeneities. Larger studies in 
different regions of the country, as well as the analysis of 
data at national level will be fundamental for establishing 
the effectiveness of the CUE in our setting. These analyses 
are essential to maintain the greatest possible safety in the 
transfusion procedures, avoiding unnecessary disposal of 
blood components and rationalizing the costs of the national 
blood therapy activities.
In conclusion, the CUE effectiveness depends on the 
context so that evaluations should be carried out locally 
in order to explore the balance between unnecessarily 
wasted blood units and improvements in donor screening. 
It remains unknown whether the CUE effectively helps 
preventing the TTI that are not detected by laboratory tests. 
Improvements in the CUE process could be explored as an 
additional strategy to ensure the safety of recipients in the 
blood donation setting.
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